Heather Wakelee
Heather Wakelee
Professor of Medicine, Stanford University
Verified email at
Cited by
Cited by
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ...
Nature medicine 20 (5), 548-554, 2014
Integrated digital error suppression for improved detection of circulating tumor DNA
AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ...
Nature biotechnology 34 (5), 547-555, 2016
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J Mazieres, A Drilon, A Lusque, L Mhanna, AB Cortot, L Mezquita, ...
Annals of Oncology 30 (8), 1321-1328, 2019
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
E Felip, N Altorki, C Zhou, T Csőszi, I Vynnychenko, O Goloborodko, ...
The Lancet 398 (10308), 1344-1357, 2021
Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer
LV Sequist, JC Soria, JW Goldman, HA Wakelee, SM Gadgeel, A Varga, ...
New England Journal of Medicine 372 (18), 1700-1709, 2015
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling
AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ...
Cancer discovery 7 (12), 1394-1403, 2017
American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non …
VL Keedy, S Temin, MR Somerfield, MB Beasley, DH Johnson, ...
Journal of clinical oncology 29 (15), 2121-2127, 2011
Lung cancer incidence in never smokers
HA Wakelee, ET Chang, SL Gomez, TH Keegan, D Feskanich, CA Clarke, ...
Journal of Clinical Oncology 25 (5), 472-478, 2007
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
MC Garassino, JG Whisenant, LC Huang, A Trama, V Torri, F Agustoni, ...
The Lancet Oncology 21 (7), 914-922, 2020
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ...
Nature communications 7 (1), 1-15, 2016
Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC
C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ...
Journal of thoracic oncology 13 (9), 1248-1268, 2018
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor
Z Piotrowska, MJ Niederst, CA Karlovich, HA Wakelee, JW Neal, ...
Cancer discovery 5 (7), 713-722, 2015
Integrating genomic features for non-invasive early lung cancer detection
JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ...
Nature 580 (7802), 245-251, 2020
First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers
BI Sikic, N Lakhani, A Patnaik, SA Shah, SR Chandana, D Rasco, ...
Journal of Clinical Oncology 37 (12), 946-953, 2019
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
RT Chlebowski, AG Schwartz, H Wakelee, GL Anderson, ML Stefanick, ...
The Lancet 374 (9697), 1243-1251, 2009
Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer
C Rolfo, P Mack, GV Scagliotti, C Aggarwal, ME Arcila, F Barlesi, T Bivona, ...
Journal of Thoracic Oncology 16 (10), 1647-1662, 2021
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non–Small-Cell Lung Cancer Previously Treated …
L Crino, MJ Ahn, F De Marinis, HJM Groen, H Wakelee, T Hida, T Mok, ...
Journal of Clinical Oncology 34 (24), 2866-2873, 2016
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
N Marcoux, SN Gettinger, G O’Kane, KC Arbour, JW Neal, H Husain, ...
Journal of Clinical Oncology 37 (4), 278-285, 2019
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone, D Owen, R Camidge, ...
Journal of Clinical Oncology 35 (13), 1403-1410, 2017
Scientific advances in lung cancer 2015
AS Tsao, GV Scagliotti, PA Bunn Jr, DP Carbone, GW Warren, C Bai, ...
Journal of Thoracic Oncology 11 (5), 613-638, 2016
The system can't perform the operation now. Try again later.
Articles 1–20